BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11334720)

  • 1. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
    Vickery CW; Blazeby JM; Conroy T; Arraras J; Sezer O; Koller M; Rosemeyer D; Johnson CD; Alderson D;
    Eur J Cancer; 2001 May; 37(8):966-71. PubMed ID: 11334720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
    Kavadas V; Blazeby JM; Conroy T; Sezer O; Holzner B; Koller M; Buckels J;
    Eur J Cancer; 2003 Jun; 39(9):1259-63. PubMed ID: 12763214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer.
    Vickery CW; Blazeby JM; Conroy T; Johnson CD; Alderson D
    Br J Surg; 2000 Mar; 87(3):362-73. PubMed ID: 10718972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life.
    Fitzsimmons D; Johnson CD; George S; Payne S; Sandberg AA; Bassi C; Beger HG; Birk D; Büchler MW; Dervenis C; Fernandez Cruz L; Friess H; Grahm AL; Jeekel J; Laugier R; Meyer D; Singer MW; Tihanyi T
    Eur J Cancer; 1999 Jun; 35(6):939-41. PubMed ID: 10533475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
    Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
    Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the EORTC STO-22 and the FACT-Ga quality of life questionnaires for patients with gastric cancer.
    Woo A; Fu T; Popovic M; Chow E; Cella D; Wong CS; Lam H; Pulenzas N; Lechner B; Vuong S; Ganesh V; Bottomley A
    Ann Palliat Med; 2016 Jan; 5(1):13-21. PubMed ID: 26841811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
    Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
    Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
    Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
    Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.
    Blazeby JM; Alderson D; Winstone K; Steyn R; Hammerlid E; Arraras J; Farndon JR
    Eur J Cancer; 1996 Oct; 32A(11):1912-7. PubMed ID: 8943674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
    Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
    Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric analysis of a Persian version of the European Organization for Research and Treatment of Cancer OG25 Quality of Life Questionnaire in oesophagogastric cancer patients.
    Hesari AE; Lari MA; Shandiz FH
    Asian Pac J Cancer Prev; 2014; 15(6):2739-45. PubMed ID: 24761894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with gastric cancer: translation and psychometric evaluation of the Iranian version of EORTC QLQ-STO22.
    Sadighi S; Montazeri A; Sedighi Z; Mohagheghi MA; Froutan H
    BMC Cancer; 2009 Aug; 9():305. PubMed ID: 19715606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
    Sprangers MA; te Velde A; Aaronson NK
    Eur J Cancer; 1999 Feb; 35(2):238-47. PubMed ID: 10448266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
    Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
    Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
    Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
    Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
    Sodergren SC; Johnson CD; Gilbert A; Tomaszewski KA; Chu W; Chung HT; Dennis K; Desideri I; Glynne-Jones R; Grønlie Guren M; Kardamakis D; Nugent K; Schmidt H; Sebag-Montefiore D; Vassiliou V;
    Radiother Oncol; 2018 Feb; 126(2):222-228. PubMed ID: 29217122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.